Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 2a trial of AZD 1656 in systemic lupus erythematosus

Trial Profile

Phase 2a trial of AZD 1656 in systemic lupus erythematosus

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 25 Mar 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AZD 1656 (Primary)
  • Indications Lupus nephritis; Systemic lupus erythematosus
  • Focus Therapeutic Use

Most Recent Events

  • 19 Mar 2025 According to Conduit Pharmaceuticals media release, the company will provide further updates on the finalization of the trial design and contracting for the study.
  • 16 Aug 2024 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top